Article
Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis
7 Nov 2018
Abstract excerpt
Abstract Gene therapy has always been a promising therapeutic approach for Cystic Fibrosis (CF). However, numerous trials using DNA or viral vectors encoding the correct protein resulted in a general low efficacy. In the last years, chemically modified messenger RNA (cmRNA) has been proven to be a highly potent, pulmonary drug. Consequently, we first explored the expression, function and immunogenicity of human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
